Pagan Douglas W. Insider Trades

Insider Trading History

Track insider trading activity for Pagan Douglas W.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Tender)Reported as Tender on SEC Form 4.
$297k 7,775 shares
$38.25
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Financial Officer
Holding Value $0 0 shares
Last Trade
Dec 28, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$5.3M 138,700 shares
$38.22
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Financial Officer
Holding Value $235k 6,150 shares
Last Trade
Dec 15, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$78k 2,050 shares
$38.05
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Financial Officer
Holding Value $320k 8,377 shares
Last Trade
Dec 15, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$78k 2,050 shares
$38.05
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Financial Officer
Holding Value $297k 7,775 shares
Last Trade
Dec 15, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$22.9k 602 shares
$38.05
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Financial Officer
Holding Value $783k 20,475 shares
Last Trade
Jun 15, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$244k 6,825 shares
$35.74
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Financial Officer
Holding Value $220k 5,760 shares
Last Trade
Jun 15, 2021 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$71.6k 2,004 shares
$35.74
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Financial Officer
Holding Value $297k 7,764 shares
Last Trade
Jun 15, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$244k 6,825 shares
$35.74
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Financial Officer
Holding Value $1.41M 36,900 shares
Last Trade
Jan 12, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.08M 45,100 shares
$24.05
$38.22
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals DRNA
Chief Financial Officer
Holding Value $3.66M 95,650 shares
Last Trade
Jun 01, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.56M 122,950 shares
$20.79
$38.22
Ziopharm Oncology
Ziopharm Oncology ZIOP
Director
Holding Value $48.5k 55,997 shares
Last Trade
Dec 31, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$119k 25,281 shares
$4.72
$0.87
Alaunos Therapeutics
Alaunos Therapeutics TCRT
Director
Holding Value $147k 55,997 shares
Last Trade
Dec 31, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29.1M 41,171 shares
$708.00
$2.62
Alaunos Therapeutics
Alaunos Therapeutics TCRT
Director
Holding Value $94.2k 35,943 shares
Last Trade
Dec 31, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$14.2M 20,054 shares
$708.00
$2.62
Ziopharm Oncology
Ziopharm Oncology ZIOP
Director
Holding Value $31.1k 35,943 shares
Last Trade
Dec 31, 2019 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$94.7k 20,054 shares
$4.72
$0.87
Paratek Pharmaceuticals
Paratek Pharmaceuticals PRTK
Chief Financial Officer
Holding Value $225k 100,807 shares
Last Trade
Apr 05, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$188k 30,000 shares
$6.28
$2.23
Paratek Pharmaceuticals
Paratek Pharmaceuticals PRTK
Chief Financial Officer
Holding Value $338k 151,557 shares
Last Trade
Apr 05, 2019 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$630k 100,250 shares
$6.28
$2.23
Paratek Pharmaceuticals
Paratek Pharmaceuticals PRTK
Chief Financial Officer
Holding Value $381k 171,057 shares
Last Trade
Feb 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$268k 37,000 shares
$7.23
$2.23
Paratek Pharmaceuticals
Paratek Pharmaceuticals PRTK
Chief Financial Officer
Holding Value $299k 134,057 shares
Last Trade
Feb 05, 2019 Sale (Open Market)Shares sold on the open market or in a private sale.
$16.9k 2,495 shares
$6.77
$2.23
Paratek Pharmaceuticals
Paratek Pharmaceuticals PRTK
Chief Financial Officer
Holding Value $305k 136,552 shares
Last Trade
Feb 01, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$109k 16,250 shares
$6.71
$2.23
Alaunos Therapeutics
Alaunos Therapeutics TCRT
Director
Holding Value $166k 63,350 shares
Last Trade
Dec 31, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$29M 103,457 shares
$280.50
$2.62

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up